Daiken Biomedical Co., Ltd. (TPE:7780)

Daiken Biomedical Statistics

Total Valuation

TPE:7780 has a market cap or net worth of TWD 15.27 billion. The enterprise value is 10.23 billion.

Market Cap	15.27B
Enterprise Value	10.23B

Important Dates

The last earnings date was Wednesday, November 12, 2025.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	Nov 24, 2025

Share Statistics

TPE:7780 has 81.00 million shares outstanding. The number of shares has increased by 77.82% in one year.

Current Share Class	81.00M
Shares Outstanding	81.00M
Shares Change (YoY)	+77.82%
Shares Change (QoQ)	+9.52%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.27%
Float	25.34M

Valuation Ratios

The trailing PE ratio is 43.15 and the forward PE ratio is 35.84.

PE Ratio	43.15
Forward PE	35.84
PS Ratio	8.56
PB Ratio	2.85
P/TBV Ratio	2.86
P/FCF Ratio	51.73
P/OCF Ratio	51.63
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 36.61, with an EV/FCF ratio of 34.64.

EV / Earnings	38.06
EV / Sales	5.74
EV / EBITDA	36.61
EV / EBIT	37.47
EV / FCF	34.64

Financial Position

The company has a current ratio of 19.43, with a Debt / Equity ratio of 0.00.

Current Ratio	19.43
Quick Ratio	17.91
Debt / Equity	0.00
Debt / EBITDA	0.07
Debt / FCF	0.06
Interest Coverage	239.58

Financial Efficiency

Return on equity (ROE) is 8.09% and return on invested capital (ROIC) is 4.91%.

Return on Equity (ROE)	8.09%
Return on Assets (ROA)	4.63%
Return on Invested Capital (ROIC)	4.91%
Return on Capital Employed (ROCE)	5.09%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	20
Asset Turnover	0.48
Inventory Turnover	1.78

Taxes

In the past 12 months, TPE:7780 has paid 65.50 million in taxes.

Income Tax	65.50M
Effective Tax Rate	19.60%

Stock Price Statistics

The stock price has increased by +17.83% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+17.83%
50-Day Moving Average	185.81
200-Day Moving Average	208.69
Relative Strength Index (RSI)	56.10
Average Volume (20 Days)	311,229

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPE:7780 had revenue of TWD 1.78 billion and earned 268.63 million in profits. Earnings per share was 4.37.

Revenue	1.78B
Gross Profit	1.15B
Operating Income	272.88M
Pretax Income	334.13M
Net Income	268.63M
EBITDA	279.28M
EBIT	272.88M
Earnings Per Share (EPS)	4.37

Balance Sheet

The company has 5.06 billion in cash and 19.16 million in debt, giving a net cash position of 5.04 billion or 62.26 per share.

Cash & Cash Equivalents	5.06B
Total Debt	19.16M
Net Cash	5.04B
Net Cash Per Share	62.26
Equity (Book Value)	5.35B
Book Value Per Share	66.03
Working Capital	5.32B

Cash Flow

In the last 12 months, operating cash flow was 295.74 million and capital expenditures -585,000, giving a free cash flow of 295.15 million.

Operating Cash Flow	295.74M
Capital Expenditures	-585,000
Free Cash Flow	295.15M
FCF Per Share	3.64

Margins

Gross margin is 64.46%, with operating and profit margins of 15.31% and 15.07%.

Gross Margin	64.46%
Operating Margin	15.31%
Pretax Margin	18.74%
Profit Margin	15.07%
EBITDA Margin	15.66%
EBIT Margin	15.31%
FCF Margin	16.55%

Dividends & Yields

This stock pays an annual dividend of 5.49, which amounts to a dividend yield of 2.89%.

Dividend Per Share	5.49
Dividend Yield	2.89%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	193.78%
Buyback Yield	-77.82%
Shareholder Yield	-74.87%
Earnings Yield	1.76%
FCF Yield	1.93%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPE:7780 has an Altman Z-Score of 25.48 and a Piotroski F-Score of 6.

Altman Z-Score	25.48
Piotroski F-Score	6